Serum seeks emergency use approval for vaccine
December 07, 2020  09:04
image
Pune-based Serum Institute of India has applied for emergency use approval for Oxford University-AstraZenecas Covid-19 vaccine candidate, Covishield. 

This makes SII, which is conducting trials of Covishield in India, the second firm to seek approval for emergency use of a Covid-19 vaccine candidate in India after Pfizer, as well as the first indigenous firm to do so.

Also in Pune, phase 2 human trials of Russias Sputnik V have begun with 17 volunteers being administered the first dose. The shots were administered at the Noble Hospital between December 3-5. On August 11, Russia had become the first country to register a Covid-19 vaccine-Sputnik V.
« Back to LIVE

TOP STORIES